{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T16:18:40Z","timestamp":1776356320958,"version":"3.51.2"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T00:00:00Z","timestamp":1703721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 110-2314-B-002-247"],"award-info":[{"award-number":["MOST 110-2314-B-002-247"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 111-230-B-002-023"],"award-info":[{"award-number":["MOST 111-230-B-002-023"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 111-2314-B-002-145"],"award-info":[{"award-number":["MOST 111-2314-B-002-145"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST 112-2320-B-002-040"],"award-info":[{"award-number":["MOST 112-2320-B-002-040"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Taiwan University Cancer Center","award":["NTUCCS 112-07"],"award-info":[{"award-number":["NTUCCS 112-07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10875-023-01643-z","type":"journal-article","created":{"date-parts":[[2023,12,28]],"date-time":"2023-12-28T05:03:58Z","timestamp":1703739838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CXCL9 as a Reliable Biomarker for Discriminating Anti\u2013IFN-\u03b3-Autoantibody\u2013Associated Lymphadenopathy that Mimics Lymphoma"],"prefix":"10.1007","volume":"44","author":[{"given":"Chang-Tsu","family":"Yuan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Ting","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Lang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Hua","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8182-6071","authenticated-orcid":false,"given":"Un-In","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jann-Tay","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang-Huei","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yee-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Chwen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,28]]},"reference":[{"issue":"1","key":"1643_CR1","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1086\/380453","volume":"38","author":"R D\u00f6ffinger","year":"2004","unstructured":"D\u00f6ffinger R, Helbert MR, Barcenas-Morales G, et al. Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis. 2004;38(1):e10-14. https:\/\/doi.org\/10.1086\/380453.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"1643_CR2","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2003-04-1065","volume":"103","author":"C H\u00f6flich","year":"2004","unstructured":"H\u00f6flich C, Sabat R, Rosseau S, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood. 2004;103(2):673\u20135. https:\/\/doi.org\/10.1182\/blood-2003-04-1065.","journal-title":"Blood"},{"issue":"8","key":"1643_CR3","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1111160.","journal-title":"N Engl J Med"},{"issue":"1","key":"1643_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","volume":"71","author":"GH Hong","year":"2020","unstructured":"Hong GH, Ortega-Villa AM, Hunsberger S, et al. Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States. Clin Infect Dis. 2020;71(1):53\u201362. https:\/\/doi.org\/10.1093\/cid\/ciz786.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"1643_CR5","doi-asserted-by":"publisher","first-page":"1684.e1","DOI":"10.1016\/j.cmi.2020.02.030","volume":"26","author":"UI Wu","year":"2020","unstructured":"Wu UI, Wang JT, Sheng WH, et al. Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies. Clin Microbiol Infect. 2020;26(12):1684.e1-1684.e6. https:\/\/doi.org\/10.1016\/j.cmi.2020.02.030.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"1643_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.diagmicrobio.2017.05.011","volume":"88","author":"I Hase","year":"2017","unstructured":"Hase I, Morimoto K, Sakagami T, Ishii Y, van Ingen J. Patient ethnicity and causative species determine the manifestations of anti-interferon-gamma autoantibody-associated nontuberculous mycobacterial disease: a review. Diagn Microbiol Infect Dis. 2017;88(4):308\u201315. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.05.011.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"8","key":"1643_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1097\/PAS.0000000000001731","volume":"45","author":"CT Yuan","year":"2021","unstructured":"Yuan CT, Wang JT, Sheng WH, et al. Lymphadenopathy associated with neutralizing anti-interferon-gamma autoantibodies could have monoclonal T-cell proliferation indistinguishable from malignant lymphoma and treatable by antibiotics: a clinicopathologic study. Am J Surg Pathol. 2021;45(8):1138\u201350. https:\/\/doi.org\/10.1097\/PAS.0000000000001731.","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"1643_CR8","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1097\/PAS.0000000000001736","volume":"45","author":"B Thingujam","year":"2021","unstructured":"Thingujam B, Syue LS, Wang RC, et al. Morphologic spectrum of lymphadenopathy in adult-onset immunodeficiency (anti-interferon-\u03b3 autoantibodies). Am J Surg Pathol. 2021;45(11):1561\u201372. https:\/\/doi.org\/10.1097\/PAS.0000000000001736.","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"1643_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003927","volume":"95","author":"CY Chi","year":"2016","unstructured":"Chi CY, Lin CH, Ho MW, et al. Clinical manifestations, course, and outcome of patients with neutralizing anti-interferon-\u03b3 autoantibodies and disseminated nontuberculous mycobacterial infections. Medicine (Baltimore). 2016;95(25): e3927. https:\/\/doi.org\/10.1097\/MD.0000000000003927.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1643_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00430-018-0555-0","volume":"208","author":"Y Koizumi","year":"2019","unstructured":"Koizumi Y, Sakagami T, Minamiguchi H, et al. Chylous ascites, anti-interferon-gamma autoantibody, and angioimmunoblastic T-cell lymphoma: a rare but intriguing connection over Mycobacterium avium. Med Microbiol Immunol. 2019;208(1):33\u20137. https:\/\/doi.org\/10.1007\/s00430-018-0555-0.","journal-title":"Med Microbiol Immunol"},{"issue":"11","key":"1643_CR11","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jiac.2022.07.015","volume":"28","author":"T Tanigaki","year":"2022","unstructured":"Tanigaki T, Kimizuka Y, Maki Y, et al. Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: a case report. J Infect Chemother. 2022;28(11):1562\u20136. https:\/\/doi.org\/10.1016\/j.jiac.2022.07.015.","journal-title":"J Infect Chemother"},{"issue":"3","key":"1643_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1007\/s10875-022-01210-y","volume":"42","author":"YC Chen","year":"2022","unstructured":"Chen YC, Weng SW, Ding JY, et al. Clinicopathological manifestations and immune phenotypes in adult-onset immunodeficiency with anti-interferon-\u03b3 autoantibodies. J Clin Immunol. 2022;42(3):672\u201383. https:\/\/doi.org\/10.1007\/s10875-022-01210-y.","journal-title":"J Clin Immunol"},{"key":"1643_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-015-0088-7","volume":"3","author":"A Cesano","year":"2015","unstructured":"Cesano A. nCounter(\u00ae) PanCancer Immune Profiling panel (NanoString Technologies Inc, Seattle, WA). J Immunother Cancer. 2015;3:42. https:\/\/doi.org\/10.1186\/s40425-015-0088-7.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"1643_CR14","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1214\/aos\/1013699998","volume":"29","author":"Y Benjamini","year":"2001","unstructured":"Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29(4):1165\u201388. https:\/\/doi.org\/10.1214\/aos\/1013699998.","journal-title":"Ann Stat"},{"issue":"43","key":"1643_CR15","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1643_CR16","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40425-017-0215-8","volume":"5","author":"P Danaher","year":"2017","unstructured":"Danaher P, Warren S, Dennis L, et al. Gene expression markers of tumor infiltrating leukocytes. J Immunother Cancer. 2017;5:18. https:\/\/doi.org\/10.1186\/s40425-017-0215-8.","journal-title":"J Immunother Cancer"},{"key":"1643_CR17","unstructured":"R Core Team. R: A language and environment for statistical computing. Published online 2022. https:\/\/www.R-project.org\/\u00a0Accessed 31 Dec 2022."},{"key":"1643_CR18","unstructured":"RStudio Team. RStudio: integrated development environment for R. Published online 2022. http:\/\/www.rstudio.com\/\u00a0Accessed 31 Dec 2022."},{"issue":"15","key":"1643_CR19","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.2169\/internalmedicine.8366-21","volume":"61","author":"C Hidekawa","year":"2022","unstructured":"Hidekawa C, Yoshimi R, Kishimoto D, et al. Anti-interferon-\u03b3 antibody-seropositive disseminated nontuberculous mycobacterial infection mimicking POEMS and TAFRO syndromes. Intern Med. 2022;61(15):2377\u201385. https:\/\/doi.org\/10.2169\/internalmedicine.8366-21.","journal-title":"Intern Med"},{"key":"1643_CR20","unstructured":"Lim M, Chan J, Sandeep, Dave S et al. Nodal TFH cell lymphoma, angioimmunoblastic-type. In: WHO Classification of Tumours Editorial Board. Haematolymphoid Tumours [Internet; Beta Version Ahead of Print]. 5th ed. International Agency for Research on Cancer. https:\/\/tumourclassification.iarc.who.int\/chaptercontent\/63\/240\u00a0Accessed 30 June 2023."},{"issue":"11","key":"1643_CR21","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","volume":"140","author":"E Campo","year":"2022","unstructured":"Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229\u201353. https:\/\/doi.org\/10.1182\/blood.2022015851.","journal-title":"Blood"},{"issue":"5","key":"1643_CR22","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","volume":"182","author":"F Liao","year":"1995","unstructured":"Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM. Human Mig chemokine: biochemical and functional characterization. J Exp Med. 1995;182(5):1301\u201314. https:\/\/doi.org\/10.1084\/jem.182.5.1301.","journal-title":"J Exp Med"},{"issue":"23","key":"1643_CR23","doi-asserted-by":"publisher","first-page":"14899","DOI":"10.1074\/jbc.272.23.14899","volume":"272","author":"Y Ohmori","year":"1997","unstructured":"Ohmori Y, Schreiber RD, Hamilton TA. Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem. 1997;272(23):14899\u2013907. https:\/\/doi.org\/10.1074\/jbc.272.23.14899.","journal-title":"J Biol Chem"},{"issue":"10","key":"1643_CR24","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1182\/blood-2004-08-2992","volume":"105","author":"G Muehlinghaus","year":"2005","unstructured":"Muehlinghaus G, Cigliano L, Huehn S, et al. Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. Blood. 2005;105(10):3965\u201371. https:\/\/doi.org\/10.1182\/blood-2004-08-2992.","journal-title":"Blood"},{"issue":"37","key":"1643_CR25","doi-asserted-by":"publisher","first-page":"22878","DOI":"10.1074\/jbc.271.37.22878","volume":"271","author":"MR Rani","year":"1996","unstructured":"Rani MR, Foster GR, Leung S, Leaman D, Stark GR, Ransohoff RM. Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha. J Biol Chem. 1996;271(37):22878\u201384. https:\/\/doi.org\/10.1074\/jbc.271.37.22878.","journal-title":"J Biol Chem"},{"issue":"8","key":"1643_CR26","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1182\/blood-2006-08-040337","volume":"109","author":"C Qian","year":"2007","unstructured":"Qian C, An H, Yu Y, Liu S, Cao X. TLR agonists induce regulatory dendritic cells to recruit Th1 cells via preferential IP-10 secretion and inhibit Th1 proliferation. Blood. 2007;109(8):3308\u201315. https:\/\/doi.org\/10.1182\/blood-2006-08-040337.","journal-title":"Blood"},{"issue":"24","key":"1643_CR27","first-page":"8028","volume":"50","author":"K Ohnishi","year":"1990","unstructured":"Ohnishi K, Ichikawa A, Kagami Y, et al. Interleukin 4 and gamma-interferon may play a role in the histopathogenesis of peripheral T-cell lymphoma. Cancer Res. 1990;50(24):8028\u201333.","journal-title":"Cancer Res"},{"issue":"4","key":"1643_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1365-2141.1990.tb07786.x","volume":"75","author":"G Pizzolo","year":"1990","unstructured":"Pizzolo G, Stein H, Josimovic-Alasevic O, et al. Increased serum levels of soluble IL-2 receptor, CD30 and CD8 molecules, and gamma-interferon in angioimmunoblastic lymphadenopathy: possible pathogenetic role of immunoactivation mechanisms. Br J Haematol. 1990;75(4):485\u20138. https:\/\/doi.org\/10.1111\/j.1365-2141.1990.tb07786.x.","journal-title":"Br J Haematol"},{"issue":"1","key":"1643_CR29","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/annonc\/mdv486","volume":"27","author":"M Gupta","year":"2016","unstructured":"Gupta M, Stenson M, O\u2019Byrne M, et al. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2R\u03b1 as predictors of event-free survival in T-cell lymphoma. Ann Oncol. 2016;27(1):165\u201372. https:\/\/doi.org\/10.1093\/annonc\/mdv486.","journal-title":"Ann Oncol"},{"issue":"5","key":"1643_CR30","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1182\/blood-2009-06-227579","volume":"115","author":"J Iqbal","year":"2010","unstructured":"Iqbal J, Weisenburger DD, Greiner TC, et al. Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma. Blood. 2010;115(5):1026\u201336. https:\/\/doi.org\/10.1182\/blood-2009-06-227579.","journal-title":"Blood"},{"issue":"5","key":"1643_CR31","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.immuni.2012.10.010","volume":"37","author":"SK Lee","year":"2012","unstructured":"Lee SK, Silva DG, Martin JL, et al. Interferon-\u03b3 excess leads to pathogenic accumulation of follicular helper T cells and germinal centers. Immunity. 2012;37(5):880\u201392. https:\/\/doi.org\/10.1016\/j.immuni.2012.10.010.","journal-title":"Immunity"},{"issue":"4","key":"1643_CR32","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/ijc.10218","volume":"98","author":"K Ohshima","year":"2002","unstructured":"Ohshima K, Tutiya T, Yamaguchi T, et al. Infiltration of Th1 and Th2 lymphocytes around Hodgkin and Reed-Sternberg (H&RS) cells in Hodgkin disease: relation with expression of CXC and CC chemokines on H&RS cells. Int J Cancer. 2002;98(4):567\u201372. https:\/\/doi.org\/10.1002\/ijc.10218.","journal-title":"Int J Cancer"},{"issue":"10","key":"1643_CR33","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.3390\/cancers11101484","volume":"11","author":"O Goncharova","year":"2019","unstructured":"Goncharova O, Flinner N, Bein J, et al. Migration properties distinguish tumor cells of classical Hodgkin lymphoma from anaplastic large cell lymphoma cells. Cancers (Basel). 2019;11(10):1484. https:\/\/doi.org\/10.3390\/cancers11101484.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1643_CR34","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138(3):825\u201338. https:\/\/doi.org\/10.1016\/j.jaci.2015.12.1330.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1643_CR35","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2007-03-080648","volume":"111","author":"A Guihot","year":"2008","unstructured":"Guihot A, Oksenhendler E, Galicier L, et al. Multicentric Castleman disease is associated with polyfunctional effector memory HHV-8-specific CD8+ T cells. Blood. 2008;111(3):1387\u201395. https:\/\/doi.org\/10.1182\/blood-2007-03-080648.","journal-title":"Blood"},{"issue":"Supplement 1","key":"1643_CR36","doi-asserted-by":"publisher","first-page":"5500","DOI":"10.1182\/blood-2022-167829","volume":"140","author":"M Mumau","year":"2022","unstructured":"Mumau M, Pierson SK, Gonzalez M, Canna S, Fajgenbaum DC. Serum proteomics identifies interferon gamma signaling in idiopathic multicentric Castleman disease. Blood. 2022;140(Supplement 1):5500\u20131. https:\/\/doi.org\/10.1182\/blood-2022-167829.","journal-title":"Blood"},{"issue":"1","key":"1643_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ajcp\/aqab090","volume":"156","author":"Y Xie","year":"2021","unstructured":"Xie Y, Jaffe ES. How I diagnose angioimmunoblastic T-cell lymphoma. Am J Clin Pathol. 2021;156(1):1\u201314. https:\/\/doi.org\/10.1093\/ajcp\/aqab090.","journal-title":"Am J Clin Pathol"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01643-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-023-01643-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-023-01643-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T09:22:51Z","timestamp":1706692971000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-023-01643-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["1643"],"URL":"https:\/\/doi.org\/10.1007\/s10875-023-01643-z","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,28]]},"assertion":[{"value":"17 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Research Ethics Committee of National Taiwan University Hospital (No. 201412163RIND, 202301141RIND).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Informed consent was obtained from all individual participants in the prospective observational study (No. 201412163RIND). Informed consent was approved to be waived in the retrospective observational study (No. 202301141RIND).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (there is no personal identity information in the manuscript).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"During the preparation of this work the authors used chatGPT in order to enhance the English quality of the manuscript. After using this tool, the authors carefully reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI and AI-Assisted Technologies in the Writing Process"}}],"article-number":"35"}}